The reduced form of glutathione (GSH) plays a significant role in supporting the immune system
When undergoing GLP-1 medication therapy, some individuals may experience side effects such as nausea, vomiting, or diarrhea
Rodrigues AR, Almeida H, Gouveia AM
Association between change in visual acuity and change in central subfield thickness during treatment of diabetic macular edema in participants randomized to aflibercept, bevacizumab, or ranibizumab: a post hoc analysis of the protocol T randomized clinical trial: a post hoc analysis of the protocol T randomized clinical trial
Long-term GLP-1 use has been studied extensively in obesity and diabetes populations, with well-documented safety profiles when prescribed by qualified healthcare providers
Larger sample sizes of CKD patients across the different stages of CKD are needed to make more robust evidence-based research conclusions